Author

Björn Jonsson

Observed names: B Jonsson, B Jónsson, B Jönsson, B. Jonsson, Bjorn Jonsson, Björn Jonsson, Björn G. Jonsson

Institutions: Uppsala University, Lagos University Teaching Hospital, Drottning Silvias barn- och ungdomssjukhus, Hallands sjukhus Halmstad, University of Gothenburg

Observed institutions: Uppsala University, National Board of Health and Welfare, Stockholm School of Economics, Université Paris Cité, Lagos University Teaching Hospital, Karolinska Institutet, Saint Göran Hospital, Drottning Silvias barn- och ungdomssjukhus, Hallands sjukhus Halmstad, University of Gothenburg, Umeå University

OpenAlex ID: A5113967524

Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes

2003 · Karin Ekberg, Tom Brismar, et al. · Diabetes · 186

International trends of Down syndrome 1993–2004: Births in relation to maternal age and terminations of pregnancies

2010 · Guido Cocchi, Silvia Gualdi, et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 176

Low Dose Dehydroepiandrosterone Affects Behavior in Hypopituitary Androgen-Deficient Women: A Placebo-Controlled Trial

2002 · Gudmundur Johannsson, Pia Burman, et al. · The Journal of Clinical Endocrinology & Metabolism · 174

Growth Hormone Treatment of Short Children Born Small for Gestational Age: Growth Responses with Continuous and Discontinuous Regimens Over 6 Years

2000 · Francis de Zegher, Kerstin Albertsson-Wikland, et al. · The Journal of Clinical Endocrinology & Metabolism · 155

Cost‐effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden

2006 · Gisela Kobelt, Björn Jonsson, et al. · Acta Ophthalmologica Scandinavica · 83

PDF

Levothyroxine Treatment Reduces Thyroid Size in Children and Adolescents with Chronic Autoimmune Thyroiditis

2006 · Johan Svensson, Ulla-Britt Ericsson, et al. · The Journal of Clinical Endocrinology & Metabolism · 79

Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies

1996 · F de Zegher, K Albertsson‐Wikland, et al. · Acta Paediatrica · 72

Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden

2008 · G Kobelt, J Berg, et al. · Multiple Sclerosis Journal · 51

Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years

1997 · F. de Zegher, O. Butenandt, et al. · Acta Paediatrica · 49

Isoallopregnanolone antagonize allopregnanolone-induced effects on saccadic eye velocity and self-reported sedation in humans

2014 · Sara K.S. Bengtsson, Sigrid Nyberg, et al. · Psychoneuroendocrinology · 35

Using EQ-5D to Derive General Population-based Utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)

2006 · Maria Kołtowska-Häggström, Björn Jonsson, et al. · Value in Health · 31

Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility‐weighted quality of life index: a precursor to cost–utility analysis

2007 · Maria Kołtowska‐Häggström, Paul Kind, et al. · Clinical Endocrinology · 25

PDF

2011 · Andrew Toogood, Georg Brabant, et al. · Endocrine Practice · 24

Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17β-estradiol and norethindrone acetate

2001 · Inga-Stina Ödmark, Björn Jonsson, et al. · American Journal of Obstetrics and Gynecology · 21

Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being

2004 · I-S Ödmark, T Bäckström, et al. · Gynecological Endocrinology · 15

GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients

2011 · Hugo L. Fideleff, Björn Jonsson, et al. · Journal of Pediatric Endocrinology and Metabolism · 12

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

2013 · Kristian Bolin, Rickard Sandin, et al. · Cost Effectiveness and Resource Allocation · 11

PDF

Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin

2005 · Inga-Stina Ödmark, Kjell Carlström, et al. · Maturitas · 10

Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens

2004 · I. S. Ödmark, T. Bäckström, et al. · Climacteric · 9

PCI reduces utility loss after myocardial infarction in Sweden.

2006 · Peter Lindgren, Ulf Stenestrand, et al. · 4

Hyperglycemia in Acutely Ill Non-diabetic Children in the Emergency Rooms of 2 Tertiary Hospitals in Lagos, Nigeria

2015 · Elizabeth E. Oyenusi, Abiola O. Oduwole, et al. · Pediatric Emergency Care · 3

Pcn162 Extrapolation in Trial-based Cost-effectiveness Modeling: in Search of a Standard

2010 · M Ekman, C Charbonneau, et al. · Value in Health · 2

Isolated GH deficiency of adult-onset in the KIMS database: prevalence, clinical presentation, and response to GH replacement

2008 · Felipe F. Casanueva, Roger Abs, et al. · 10th European Congress of Endocrinology · 1

Cv7 9301 Cost-effectiveness of Long-term Therapy With Clopidogrel Following Percutaneous Coronary Intervention: a Swedish Analysis of the Credo-trial

2005 · A Ringborg, P Lindgren, et al. · Value in Health · 1

PDF

Nd3: Cost-effectiveness of Cabergoline Compared to Levodopa in Early Parkinson's Disease in Sweden

2001 · P Lindgren, B Jönsson · Value in Health · 1

PDF

Works count: 44

Citation count: 1,230

H-index: 15

I10-index: 18